HIV-Infected Patients

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 1 SUPPL., 2009, Pages 142-145

  Krishnan, Amrita ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RITONAVIR; TACROLIMUS; VINBLASTINE; VINCRISTINE; ZIDOVUDINE;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; CLINICAL TRIAL; COMORBIDITY; DISEASE FREE SURVIVAL; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LYMPHOMA; MYELOABLATIVE CONDITIONING; OPPORTUNISTIC INFECTION; OVERALL SURVIVAL; PATIENT SELECTION; STEM CELL TRANSPLANTATION;

EID: 64749089911     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.10.002     Document Type: Article

References (15)

1. Henon P. Fifteen years of peripheral blood stem cell transplantation achievement. J Hematother Stem Cell Res 9 (2000) 933-934
2. Binnet F., Lewden C., May T., et al. Malignancy related causes of death in human immunodeficiency virus infected patients in the era of highly active antiretroviral therapy. Cancer 10 (2004) 317-324
3. Kaplan L.D., Strauss D.J., Testa M.A., et al. Low dose MBACOD compared with standard dose m BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. N Engl J Med 336 (1997) 1641-1648
4. Weiss R., Mitrou P., Arasteh K., et al. Acquired immunodeficiency syndrome related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival-results of the German multicenter trial. Cancer 106 (2006) 1560-1568
5. Philip T., Guglielmi C., Hagenbeek C., et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non-Hodgkin's lymphoma. N Engl J Med 333 (1995) 1540-1545
6. Linch D.C., Winfield D., Goldstone A.H., et al. Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial. Lancet 341 (1993) 1051-1054
7. Gabarre J., Choquet S., Azar N., et al. High dose chemotherapy with autologous stem cell transplant for HIV associated lymphoma. Bone Marrow Transplant 18 (1996) 1195-1197
8. Krishnan A, Zaia J, Forman S, et al. Autologous stem cell transplantation (ASCT) for AIDS-related lymphoma (ARL). Abstract 41 (to be presented at AIDS malignancy meeting, ICMAOI, Oct 2008.
9. Spitzer T., Ambinder R., and Lee J. Dose reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for HIV associated lymphoma: AIDS Malig Consortium. Biol Blood Marrow Transplant 14 (2008) 59-66
10. Balsalobre P., Serrano D., Re A., et al. Autologous stem cell transplantation (ASCT) in HIV associated lymphoma patients: the EBMT lymphoma working party experience. Blood 108 (2006) a3042
11. Martin D., Balslobre P., Re A., et al. Comparable survival between HIV + and HIV negative Hodgkin's lymphoma patients undergoing ASCT; a retrospective analysis of the EBMT lymphoma working group. Blood 110 (2007) ab24
12. Ragni M.V., Dodson S.F., Hunt S., et al. Liver transplantation in a hemophilia patient with AIDS. Hepatitis C. Blood 92 (1998) 556
13. Keever C.A., Small T.N., Flomenberg N., et al. Immune reconstituion following bone marrow transplantation: comparison of recipients of T cell depleted marrow with recipients of conventional marrow grafts. Blood 73 (1989) 1340-1350
14. Gupta V., Tomblyn M., Pederson T., et al. Allogeneic stem cell transplantation in HIV positive patients with malignant and non malignant disorders: a report from the center for international blood and marrow transplant research (CIBMTR). Biol Blood Marrow Transplant 13 (2007) 5-6
15. Krishnan A., Molina A., Zaia J., et al. Durable remissions with autologous stem cell transplantation for high-risk associated lymphomas. Blood 105 (2005) 874-878